
Top Dividend Stocks for Long-Term Passive Income
Three dividend stocks, AbbVie, Johnson & Johnson, and Pfizer, are highlighted as strong investment options. AbbVie offers a 3.6% yield and has a promising drug pipeline despite challenges with Humira. Johnson & Johnson, despite legal and regulatory hurdles, remains a stable long-term pick with a 3.21% yield. Pfizer, with a high 6.6% yield, faces concerns over COVID sales and patent cliffs but is financially solid with a strong pipeline, making it a potentially undervalued buy.
